Potential Role of Local Estrogen in Enhancement of Fracture Healing: Preclinical Study in Rabbits

Document Type : RESEARCH PAPER


1 Bone and Joint Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

2 University College London Hospital, 235 Euston Road, London, NW1 2BU UK


Background: Effects of estrogen on bone metabolism and its protective role on prevention of osteoporosis are well
documented. However, the efficacy of estrogen treatment on bone healing is not well investigated. The drug can be delivered both systemically or locally to the bone with differences in concentrations and side effects. The aim of this study was to investigate the effect of local and systemic administration of estrogen on the fracture healing process.
Standardized tibial fractures with 4 millimeter gaps were created in twenty four adult male Dutch rabbits. Fractures were fixed using intramedullary wires and long leg casts. Rabbits were randomly divided into three groups. Group A was treated with twice a week administration of long acting systemic estrogen; group B was treated with a similar regimen given locally at the fracture gap; and group C received sham normal saline injections (control). Fracture healing was assessed at six weeks post fracture by gross examination, radiographic and histomorphometric analysis.
Group B had significantly higher gross stability, radiographic union and gap reduction than the two other groups. Histomorphometric analysis showed higher cartilaginous proportion of periosteal callus area in the control group.
Our results showed that estrogen may enhance fracture healing of long bone in rabbits. Furthermore, local estrogen treatment might have better effect than systemic treatment.


Main Subjects

1. Buckwalter JA, Glimcher MJ, Cooper RR, Recker
R. Bone biology. I: Structure, blood supply, cells,
matrix, and mineralization. Instr Course Lect. 1996;
2. Buckwalter JA, Glimcher MJ, Cooper RR, Recker
R. Bone biology. II: Formation, form, modeling,
remodeling, and regulation of cell function. Instr
Course Lect. 1996; 45(8):387-99.
3. Monroe DG, Secreto FJ, Spelsberg TC. Overview of
estrogen action in osteoblasts: role of the ligand,
the receptor, and the co-regulators. J Musculoskelet
Neuronal Interact. 2003; 3(4):357-62.
4. Rath NC, Huff GR, Huff WE, Balog JM. Factors
regulating bone maturity and strength in poultry.
Poult Sci. 2000; 79(7):1024-32.
5. Ulstrup AK. Biomechanical concepts of fracture
healing in weight-bearing long bones. Acta Orthop
Belg. 2008; 74(3):291-302.
6. Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT.
Effect of IGF-I and PDGF administered in vivo on the
expression of osteoblast-related genes in old rats. J
Endocrinol. 2002; 174(1):63-70.
7. Leboy PS. Regulating bone growth and development
with bone morphogenetic proteins. Ann N Y Acad
Sci. 2006; 1068(1):14-8.
8. Vanderschueren D, van Herck E, Nijs J, Ederveen
AG, De Coster R, Bouillon R. Aromatase inhibition
impairs skeletal modeling and decreases bone
mineral density in growing male rats. Endocrinology.
1997; 138(6):2301-7.
9. Carani C, Qin K, Simoni M, Faustini-Fustini M,
Serpente S, Boyd J, et al. Effect of testosterone and
estradiol in a man with aromatase deficiency. N Engl
J Med. 1997; 337(2):91-5.
10. Lanyon L, Armstrong V, Ong D, Zaman G, Price
J. Is estrogen receptor alpha key to controlling
bones’ resistance to fracture? J Endocrinol. 2004;
11. Bonnelye E, Aubin JE. Estrogen receptor-related
receptor alpha: a mediator of estrogen response in
bone. J Clin Endocrinol Metab. 2005; 90(5):3115-21.
12. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi
K, Igarashi K, et al. Estrogen prevents bone loss via
estrogen receptor alpha and induction of Fas ligand
in osteoclasts. Cell. 2007; 130(5):811-23.
13. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT,
Martin TJ. Modulation of osteoclast differentiation
and function by the new members of the tumor
necrosis factor receptor and ligand families. Endocr
Rev. 1999; 20(3):345-57.
14. Raisz LG. Pathogenesis of osteoporosis: concepts,
conflicts, and prospects. J Clin Invest. 2005;
15. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley
J, Capparelli C, et al. osteoprotegerin-deficient
mice develop early onset osteoporosis and arterial
calcification. Genes Dev. 1998; 12(9):1260-8.
16. Shevde NK, Bendixen AC, Dienger KM, Pike JW.
Estrogens suppress RANK ligand-induced osteoclast
differentiation via a stromal cell independent
mechanism involving c-Jun repression. Proc Natl
Acad Sci U S A. 2000; 97(14):7829-34.
17. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and
the construction and conservation of the adult
skeleton. Endocr Rev. 2002; 23(3):279-302.
18. He YX, Liu Z, Pan XH, Tang T, Guo BS, Zheng LZ, et al.
Deletion of estrogen receptor beta accelerates early
stage of bone healing in a mouse osteotomy model.
Osteoporos Int. 2012; 23(1):377-89.
19. Beil FT, Barvencik F, Gebauer M, Beil B, Pogoda P,
Rueger JM, et al. Effects of increased bone formation
on fracture healing in mice. J Trauma. 2010;
20. Monaghan BA, Kaplan FS, Lyttle CR, Fallon MD,
Boden SD, Haddad JG. Estrogen receptors in fracture
healing. Clin Orthop Relat Res. 1992; 280:277-80.21.
21. Nissenson R, Fluoret G, Hechter O. Opposing effects
of estradiol and progesterone on oxytocin receptors
in rabbit uterus. Proc Natl Acad Sci U S A. 1978;
22. Lin AD, Mannikarottu A, Kogan BA, Whitbeck C,
Chichester P, Leggett RE, et al. Estrogen induces
angiogenesis of the female rabbit bladder. J
Endocrinol. 2006; 190(2):241-6.
23. Negulesco JA, Eglitis JA. Effect of hypophysectomy
and estrogen treatment on long bone fracture
healing of young domestic fowls. Ohio J Sci. 1975;
24. Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-
Wuttke D, Tezval M, et al. Estrogen and raloxifene
improve metaphyseal fracture healing in the early
phase of osteoporosis. A new fracture-healing model
at the tibia in rat. Langenbecks Arch Surg. 2010;
25. Ahmad MA, Kuhanendran D, Kamande IW,
Charalambides C. Accelerated tibial fracture union
in the third trimester of pregnancy: a case report. J
Med Case Rep. 2008; 2(1):44.